Get the Stockscreener App
17.30
0.46%
-0.08
After Hours:
17.28
-0.02
-0.12%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $17.30, with a volume of 12.18M.
It is down -0.46% in the last 24 hours and down -1.09% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
See More
Previous Close:
$17.38
Open:
$17.35
24h Volume:
12.18M
Relative Volume:
0.32
Market Cap:
$33.21B
Revenue:
$15.12B
Net Income/Loss:
$1.47B
P/E Ratio:
22.64
EPS:
0.764
Net Cash Flow:
$1.72B
1W Performance:
-0.23%
1M Performance:
-1.09%
6M Performance:
+6.40%
1Y Performance:
-24.49%
1-Day Range:
$17.16
$17.39
1-Week Range:
$17.11
$17.56
52-Week Range:
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
17.30 | 33.37B | 15.12B | 1.47B | 1.72B | 0.764 |
PG
Procter Gamble Co
|
143.38 | 335.54B | 85.26B | 16.53B | 14.85B | 6.7488 |
UL
Unilever Plc Adr
|
58.09 | 126.25B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
83.49 | 67.52B | 20.38B | 2.26B | 3.63B | 2.6214 |
KMB
Kimberly Clark Corp
|
96.81 | 32.25B | 17.23B | 1.75B | 1.64B | 6.0654 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal - WHTC
Looking for a High-Yield Alternative to Costco Wholesale and Walmart? Consider This Dirt Cheap Dividend King Stock. - The Motley Fool
Kimberly-Clark shares tick higher after post-acquisition leadership plans revealed - MSN
Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal - WSJ
Kimberly-Clark names leadership team for Kenvue acquisition - Investing.com
Kenvue names Heather Howlett as interim CFO following Amit Banati’s departure - Investing.com
Leadership shift at Kenvue (NYSE: KVUE) as Howlett becomes interim CFO - Stock Titan
Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership - PR Newswire
KVUE Maintained by Barclays -- Price Target Lowered to $18.00 - GuruFocus
Listerine Cool Mint: Why Oral Care Stability Matters More Now - AD HOC NEWS
Liquidity Mapping Around (KVUE) Price Events - Stock Traders Daily
Kenvue (NYSE:KVUE) Solidifies Its Position In The S&P 500 Index with Strong Growth - Kalkine Media
Sumitomo Mitsui Trust Group Inc. Grows Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. (NYSE:KVUE) Receives Average Rating of "Hold" from Analysts - MarketBeat
HF Advisory Group LLC Purchases 74,215 Shares of Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark To Acquire Kenvue In Massive $48.7B Merger - MSN
Massachusetts Financial Services Co. MA Reduces Position in Kenvue Inc. $KVUE - MarketBeat
RBC Capital Maintains Kenvue(KVUE.US) With Hold Rating, Maintains Target Price $21 - Moomoo
Alpha Omega Wealth Management LLC Sells 167,069 Shares of Kenvue Inc. $KVUE - MarketBeat
KVUE Stock Price, Quote & Chart | KENVUE INC (NYSE:KVUE) - ChartMill
Assessing Kenvue (NYSE:KVUE) Valuation After New Dermatology Data And Product Launches - simplywall.st
Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal - MSN
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Sonoma Pharmaceuticals and Kenvue Brands Sign Manufacturing and Supply Agreement for Microcyn® Technology Products Through 2027 - Minichart
Sonoma Pharmaceuticals enters manufacturing agreement with Kenvue Brands - Investing.com
Sonoma Pharmaceuticals (SNOA) signs Kenvue U.S. Microcyn manufacturing and supply deal - Stock Titan
OFI Invest Asset Management Invests $22.83 Million in Kenvue Inc. $KVUE - MarketBeat
Oak Thistle LLC Purchases Shares of 90,615 Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock rises Wednesday, outperforms market - MarketWatch
[ARS] Kenvue Inc. SEC Filing - Stock Titan
Kenvue (NYSE: KVUE) outlines Kimberly-Clark merger, 2025 pay and votes - Stock Titan
Kenvue Inc. stock falls Tuesday, underperforms market - MarketWatch
Kenvue Inc call volume above normal and directionally bullish - TipRanks
UBS Group Issues Pessimistic Forecast for Kenvue (NYSE:KVUE) Stock Price - MarketBeat
Kenvue price target lowered to $18 from $19 at UBS - TipRanks
Rep. Kevin Hern Sells Kenvue Inc. (NYSE:KVUE) Stock - MarketBeat
Kimberly-Clark Has Fallen 33%. Is KMB Stock Finally a Buy? - TIKR.com
Capricorn Fund Managers Ltd Takes $4.87 Million Position in Kenvue Inc. $KVUE - MarketBeat
T. Rowe Price Spectrum Moderate Growth Allocation Fund's Kenvue Inc(KVUE) Holding History - GuruFocus
Kenvue Inc. (KVUE): A bull case theory - MSN
141,900 Shares in Kenvue Inc. $KVUE Bought by Cohen Capital Management Inc. - MarketBeat
Kenvue Inc. (KVUE) stock price, news, quote and history - Yahoo Finance UK
Kenvue Inc. (KVUE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Why (KVUE) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Kenvue Inc. stock falls Thursday, underperforms market - MarketWatch
Kenvue Inc. $KVUE Shares Bought by HF Advisory Group LLC - MarketBeat
Jeffrey Smith (KVUE) grows deferred share units to 15,123.688 - Stock Titan
Here's Why Kenvue (KVUE) Could be Great Choice for a Bottom Fisher - Yahoo Finance
Kenvue Defends ORSL, ERZL Amid Misinformation Concerns, Reaffirms Science-Backed Hydration Strategy - Medical Dialogues
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):